Page 21 - 72_04
P. 21

VOL. 72 (4), 563-581, 2006  ABERRANT MRNA STABILITY REGULATION IN HUMAN...

(29) CORCORAN, J. A.; HSU, W. L. and SMILEY, J. R. (2006): Herpes simplex virus
        ICP27 is required for virus-induced stabilization of the ARE-containing IEX-
        1 mRNA encoded by the human IER3 gene. J. Virol. 80: 9720-9729.

(30) FAN, X. C.; MYER, V. E. and STEITZ, J. A. (1997): AU-rich elements target small
        nuclear RNAs as well as mRNAs for rapid degradation. Genes Dev. 11: 2557-
        2568.

(31) OLDENBURG, J. and EL-MAARRI, O. (2006): New insight into the molecular basis
        of hemophilia A. Int. J. Hematol. 83: 96-102.

(32) KHABAR, K. S. (2005): The AU-rich transcriptome: more than interferons and
        cytokines, and its role in disease. J. Interferon Cytokine Res. 25: 1-10.

(33) XIA, J.; BOGARDUS, C. and PROCHAZKA, M. (1999): A type 2 diabetes-associated
        polymorphic ARE motif affecting expression of PPP1R3 is involved in RNA-
        protein interactions. Mol. Genet. Metab. 68: 48-55.

(34) KLOSS, S.; RODENBACH, D.; BORDEL, R. and MULSCH, A. (2005): Human-antigen
        R (HuR) expression in hypertension: downregulation of the mRNA stabilizing
        protein HuR in genetic hypertension. Hypertension 45: 1200-1206.

(35) MOCELLIN, S.; PROVENZANO, M.; LISE, M; NITTI, D. and ROSSI, C. R. (2003):
        Increased TIA-1 gene expression in the tumor microenvironment after
        locoregional administration of tumor necrosis factor-alpha to patients with
        soft tissue limb sarcoma. Int. J. Cancer. 107: 317-322.

(36) LIN, S.; WANG, W.; WILSON, G. M; YANG, X., BREWER, G., HOLBROOK, N. J. and
        GOROSPE, M. (2000): Down-regulation of cyclin D1 expression by prostaglandin
        A(2) is mediated by enhanced cyclin D1 mRNA turnover. Mol. Cell. Biol. 20:
        7903-7913.

(37) BEVILACQUA, A.; CERIANI, M. C.; CAPACCIOLI, S. and NICOLIN, A. (2003): Post-
        transcriptional regulation of gene expression by degradation of messenger
        RNAs. J. Cell. Physiol. 195: 356-372.

(38) SAKLATVALA, J. (2004): The p38 MAP kinase pathway as a therapeutic target in
        inflammatory disease. Curr. Opin. Pharmacol. 4: 372-377.

(39) ISAACS, F. J.; DWYER, D. J.; DING, C.; PERVOUCHINE, D. D.; CANTOR, C. R. and
        COLLINS, J. J. (2004): Engineered riboregulators enable post-transcriptional
        control of gene expression. Nat. Biotechnol. 22: 841-847.

(40) MANJESHWAR, S.; BRANAM, D. E.; LERNER, M. R.; BRACKETT, D. J. and JUPE, E. R.
        (2003): Tumor suppression by the prohibitin gene 3’untranslated region RNA
        in human breast cancer. Cancer Res. 63: 5251-5256.

                            581
   16   17   18   19   20   21   22   23   24   25   26